|
Home : Unsafe Drugs : Avandia : Newsfeeds : GSK eyes healthier times beyond Q1 flu sales gap GSK eyes healthier times beyond Q1 flu sales gap
More important than the numbers will be confidence shown by management that the company's fortunes have reached a floor -- following the furore over diabetes drug Avandia and big generic hits in 2010 -- and it is now positioned for growth. Dominic Valder ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




